CEBPA and acute myeloid leukemia: Earlier study has indicated that CEBPA mutations in cytogenetically normal AML patients are associated with favourable prognosis (Frohling et al, 2004; Bienz et al, 2005; Gaidzik and Dohner (2008); Marcucci et al, 2008; Schlenk et al, 2008).